Inventor
Krishnan RAMAN
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07DHeterocyclic compounds26%
C07BGeneral methods of organic chemistry6%
C07KPeptides6%
Y02ATechnologies for adaptation to climate change6%
C07CAcyclic or carbocyclic compounds3%
PatentTitleYear
12,558,341Oral complement factor D inhibitors202612,485,109Pyrrolo 12.3-dipyrimidine compounds and analogues thereof202512,054,492Imidazole-containing inhibitors of ALK2 kinase202412,043,610Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors202411,866,418Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors202411,708,347Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors202311,661,426Imidazole-containing inhibitors of ALK2 kinase202311,559,515Indole compounds and analogues thereof202311,370,774Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to BIOCRYST PHARM INC (9)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BIOCRYST PHARM INC | 9 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 9 | 2022–2026 |